Skip to main content
Erschienen in: PharmacoEconomics 4/2003

01.03.2003 | Original Research Article

Unit Costs of Inpatient Hospital Days

verfasst von: Jan B. Oostenbrink, Tineke Buijs-Van der Woude, Michel van Agthoven, Marc A. Koopmanschap, Frans F. H. Rutten

Erschienen in: PharmacoEconomics | Ausgabe 4/2003

Einloggen, um Zugang zu erhalten

Abstract

Background: Costs of inpatient days in hospitals are frequently the main drivers of total treatment costs, and their unit cost can markedly affect the outcomes of an economic evaluation. In many countries, the availability of unit cost data is limited and unit costs are often based on data from hospitals participating in clinical trials.
Objective: To provide data about unit costs of inpatient hospital days in The Netherlands from a healthcare provider’s perspective and to give an insight into the extent to which cost categories and total costs differ between hospitals.
Design: Unit costs were collected from 22 wards and 11 intensive care units (ICUs) of general and university hospitals involved in clinical trials with ‘piggy-backed’ economic evaluations. Direct costs, such as costs of nursing and medical materials, were calculated by dividing the annual cost per category of the nursing department by the annual number of inpatient days. Indirect costs, such as overheads and accommodation, were allocated to the nursing departments by applying direct allocation. All costs were expressed in 1998 euros (EUR).
Results: The mean costs per inpatient day were EUR230 (range: EUR154–EUR311) in general hospitals and EUR323 (range: EUR209–EUR400) in university hospitals. The mean costs per inpatient day in an ICU were EUR1125 (EUR919–EUR1560). Between 38–48% of the total costs were made up of nursing costs. All cost categories showed wide variations between hospitals.
Conclusions: The results of this study were used to develop standard costs for inpatient days in The Netherlands and may contribute to the comparability and generalisability of economic evaluations.
Literatur
1.
Zurück zum Zitat Drummond MF, O’Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd ed. New York: Oxford University Press, 1997 Drummond MF, O’Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd ed. New York: Oxford University Press, 1997
2.
Zurück zum Zitat Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press, 1996 Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press, 1996
3.
Zurück zum Zitat Goeree R, Gafni A, Hannah M, et al. Hospital selection for unit cost estimates in multicentre economic evaluations; does the choice of hospitals make a difference. Pharmacoeconomics 1999; 15 (6): 561–72PubMedCrossRef Goeree R, Gafni A, Hannah M, et al. Hospital selection for unit cost estimates in multicentre economic evaluations; does the choice of hospitals make a difference. Pharmacoeconomics 1999; 15 (6): 561–72PubMedCrossRef
4.
Zurück zum Zitat Raikou M, Briggs A, Gray A, et al. Centre-specific or average unit costs in multi-centre studies?: some theory and simulation. Health Econ 2000; 9: 191–8PubMedCrossRef Raikou M, Briggs A, Gray A, et al. Centre-specific or average unit costs in multi-centre studies?: some theory and simulation. Health Econ 2000; 9: 191–8PubMedCrossRef
5.
Zurück zum Zitat Hakkaart-van Roijen L. Societal perspective on the cost of illness [PhD thesis]. Rotterdam: Erasmus Medical Center, 1998 Hakkaart-van Roijen L. Societal perspective on the cost of illness [PhD thesis]. Rotterdam: Erasmus Medical Center, 1998
6.
Zurück zum Zitat Polder JJ. Cost of illness in the Netherlands [PhD thesis]. Rotterdam: Erasmus Medical Center, 2001 Polder JJ. Cost of illness in the Netherlands [PhD thesis]. Rotterdam: Erasmus Medical Center, 2001
7.
8.
Zurück zum Zitat van Agthoven M, Vellenga E, Fibbe WE, et al. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin’s lymphoma or Hodgkin’s disease: a prospective randomised trial. Eur J Cancer 2001; 37 (14): 1781–9PubMedCrossRef van Agthoven M, Vellenga E, Fibbe WE, et al. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin’s lymphoma or Hodgkin’s disease: a prospective randomised trial. Eur J Cancer 2001; 37 (14): 1781–9PubMedCrossRef
9.
Zurück zum Zitat Oostenbrink JB, Koopmanschap MA, Rutten FFH. Manual for costing: methods and standard costs for economic evaluations in healthcare [in Dutch]. Amstelveen: College voor zorgverzekeringen, 2000 Oostenbrink JB, Koopmanschap MA, Rutten FFH. Manual for costing: methods and standard costs for economic evaluations in healthcare [in Dutch]. Amstelveen: College voor zorgverzekeringen, 2000
10.
Zurück zum Zitat Oostenbrink JB, Koopmanschap MA, Rutten FFH. Standardisation of costs; the Dutch manual for costing in economic evaluations. PharmacoEconomics 2002; 20 (7): 443–54PubMedCrossRef Oostenbrink JB, Koopmanschap MA, Rutten FFH. Standardisation of costs; the Dutch manual for costing in economic evaluations. PharmacoEconomics 2002; 20 (7): 443–54PubMedCrossRef
11.
Zurück zum Zitat Riteco JA, Heij LJM de, Luijn JCF van, et al. Dutch guidelines for pharmacoeconomic research. Amstelveen: Health Insurance Council, 1999 Mar Riteco JA, Heij LJM de, Luijn JCF van, et al. Dutch guidelines for pharmacoeconomic research. Amstelveen: Health Insurance Council, 1999 Mar
12.
Zurück zum Zitat Dutch Hospital Institute. NZI rekeningenschema voor Gezondheidszorginstellingen en verzorgingshuizen. (NZI cost accounting scheme for intramural organisations in healthcare). Utrecht: Dutch Hospital Institute, 1994 Dutch Hospital Institute. NZI rekeningenschema voor Gezondheidszorginstellingen en verzorgingshuizen. (NZI cost accounting scheme for intramural organisations in healthcare). Utrecht: Dutch Hospital Institute, 1994
13.
Zurück zum Zitat Horngren CT. Cost accounting. 5th ed. Englewood Cliffs: Prentice-Hall, 1982 Horngren CT. Cost accounting. 5th ed. Englewood Cliffs: Prentice-Hall, 1982
14.
Zurück zum Zitat Davidoff AJ, Powe NR. The role of perspective in defining economic measures for the evaluation of medical technology. Int J Technol Assess 1996; 12-1: 9–21CrossRef Davidoff AJ, Powe NR. The role of perspective in defining economic measures for the evaluation of medical technology. Int J Technol Assess 1996; 12-1: 9–21CrossRef
16.
Zurück zum Zitat Jacobs P, Roos NP. Standard cost lists for healthcare in Canada. Pharmacoeconomics 1999; 15 (6): 551–60PubMedCrossRef Jacobs P, Roos NP. Standard cost lists for healthcare in Canada. Pharmacoeconomics 1999; 15 (6): 551–60PubMedCrossRef
17.
Zurück zum Zitat Institute of Health Economics. A national list of provincial costs for health care 1997/8. Edmonton: Institute of Health Economics, 2000 Institute of Health Economics. A national list of provincial costs for health care 1997/8. Edmonton: Institute of Health Economics, 2000
18.
Metadaten
Titel
Unit Costs of Inpatient Hospital Days
verfasst von
Jan B. Oostenbrink
Tineke Buijs-Van der Woude
Michel van Agthoven
Marc A. Koopmanschap
Frans F. H. Rutten
Publikationsdatum
01.03.2003
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 4/2003
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321040-00004

Weitere Artikel der Ausgabe 4/2003

PharmacoEconomics 4/2003 Zur Ausgabe

Original Research Article

Ontario’s Formulary Committee